180 Life Sciences is a clinical-stage biotechnology company that is developing therapies to combat inflammation in patients with chronic inflammation-related illnesses The company is being acquired by special purpose acquisition corporation KBL Merger Corp. IV (NASDAQ: KBLM) and will be listed on the Nasdaq Capital Market under ticker symbol ATNF when the deal closes later … Continue reading “180 Life Sciences Corp. Pursuing Novel Solutions to Inflammatory Illnesses as Merger Nears Completion”
180 Life Sciences, a clinical-stage biotechnology company, is focused on the development of novel drugs that fulfill unmet needs for a variety of conditions including fibrosis, pain and inflammatory diseases. 180 Life Sciences will soon form a combined company with KBL Merger Corp. (NASDAQ: KBLM) (KBL Merger Corp. Rights NASDAQ: KBLMR) (KBL Merger Corp. Warrant … Continue reading “NetworkNewsBreaks – Why 180 Life Sciences Corp. Is ‘One to Watch’”
180 Life Sciences boasts a world-class team responsible for developing new classes of drugs targeting multiple disease states while creating significant shareholder value The company has a large and expanding patent portfolio The risks associated with the company’s drug development efforts are mitigated through the concurrent advancement of multiple programs in different stages of development … Continue reading “180 Life Sciences Corp. is “One to Watch””
Investment Considerations 180 Life Sciences boasts a world-class team responsible for developing new classes of drugs targeting multiple disease states while creating significant shareholder value. The company has a large and expanding patent portfolio. The risks associated with the company’s drug development efforts are mitigated through the concurrent advancement of multiple programs in different stages … Continue reading “180 Life Sciences Corp. (NASDAQ: ATNF)”
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables and specialty testing services for the worldwide life sciences and other industries, today announced its participation in the upcoming LD Micro Virtual Invitational Conference XI. The three-day, virtual investor conference will feature approximately 180 companies, presenting … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) to Present at LD Micro Virtual Invitational Conference XI”
NetworkNewsWire Editorial Coverage: Innovation and breakthroughs in the biotech industry are essential to identifying and providing life-saving treatments. Companies that invest substantial amounts of time, effort, and resources in key areas of research and innovation are critical in the advancement treatment options across the board. On the front lines of research and development in the … Continue reading “Life-Saving Advancements, Treatments Delivered by Companies Invested in Innovation”
Federal four-year grant awarded to Ohio State University to fund research program with PBIO Goal is development of manufacturing process to keep foods fresh without costly refrigerated transport/storage and safe without chemical additives PBIO’s Ultra-Shear Technology (“UST”) allows food manufacturers to manufacture healthier beverages and other foods that retain flavor and preserve product’s wholesome ingredients, … Continue reading “Pressure BioSciences, Inc. (PBIO) Patented Ultra-Shear Technology Focus of New Government-Funded Food Safety Program”
Biologics offer novel ways of treating degenerative diseases like Alzheimer’s Biologics are one of the fastest-growing drug categories PreEMT™ technology improves quality, reduces cost of biologic manufacture When we think of drugs, an image of potions in round-bottom flasks conjured up in labs comes to mind, or perhaps pills of one sort or another ingested … Continue reading “Pressure BioSciences Inc.’s (PBIO) Recently Acquired PreEMT™ Platform Enhances Development of Biotherapeutic Protein Drugs”
NetworkNewsWire Editorial Coverage: In a natural response to injury or infection, the body produces chemicals that trigger the immune system to release antibodies and proteins plus increase blood flow to the afflicted area, which aids healing and produces inflammation. However, the immune system and the inflammatory processes have pernicious aspects far removed from beneficial healing. In … Continue reading “Controlling Inflammation to Stop Disease”
NetworkNewsWire Editorial Coverage: Enormous amounts of money exchange hands in the big pharma space as companies merge and are acquired — all in search of the next blockbuster drug. While the discovery of a blockbuster drug, or a drug that generates more than $1 billion in sales per year, occurs rarely, the tremendous benefits of … Continue reading “In Pursuit of the Elusive Drug — the Billion-Dollar Blockbuster”
